|
|
Article: SIEMENS DEBUTS BONSAI FLUORESCENCE OPTICAL IMAGING TECHNOLOGY.
- Article from:
- Biotech Equipment Update
- Article date:
- October 1, 2003
CopyrightCOPYRIGHT 2003 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Siemens Medical Solutions, San Francisco, has introduced bonSAI, a fluorescence optical imaging technology that enables in vivo imaging of molecular processes. As part of Siemens' commitment to the advancement of molecular imaging, bonSAI is expected to have a profound impact on the way drugs are developed, and the way diseases are understood and treated.
"Fluorescence imaging techniques are of particular interest to drug discovery and development because of their low cost, versatility and high throughput capability," said Markus Rudin, head of the Analytical and Imaging Sciences Unit at Novartis Institute for Biomedical Research, one of several prototype-testing ...